Protalix Biotherapeutics Inc (PLX) — Free Cash Flow Generation Index
Protalix Biotherapeutics Inc (PLX) has a Free Cash Flow Generation Index of 1.61x as of December 2025. Free cash flow of $3.27 Million represents 2% of operating cash flow ($2.03 Million). See working capital position of Protalix Biotherapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Protalix Biotherapeutics Inc Free Cash Flow Generation Index (2009–2024)
Historical FCF Generation Index trend for Protalix Biotherapeutics Inc across 3 annual periods. Explore PLX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Protalix Biotherapeutics Inc (2009–2024)
Year-by-year Free Cash Flow Generation Index for Protalix Biotherapeutics Inc. For the full company profile including market capitalisation, see PLX company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.85x | $7.39 Million | $8.67 Million | $1.28 Million | ▲ +137.8% |
| 2012 | -2.26x | $-1.43 Million | $635.00K | $2.07 Million | ▼ -362.2% |
| 2009 | 0.86x | $38.26 Million | $44.45 Million | $6.20 Million | — |